Exploring CAR-T & Radiopharmaceutical Combinations in Solid Tumors for Enhanced Efficacy
Time: 10:00 am
day: Conference Day Two
Details:
- Appreciating that CAR T cells have shown limited effectiveness against solid tumors for various reasons
- Outlining the increasing evidence of the immunostimulatory effects of radiopharmaceutical therapy,
- Addressing some of the challenges faced by CAR T cell therapy especially in the metastatic setting
